This report is an analysis of the industry drivers and inhibitors within the pharmaceutical industry that will affect the take up of CRM.
Scope
Pharmaceutical companies are facing a multi-layered assault on their profit margins
Lack of ROI to date is holding pharmaceutical companies back from investing in CRM
Each region is producing differing challenges for the pharmaceutical industry
Highlights
The pharmaceutical industry is facing a number of pressures on its profit margins. This report looks at these pressures and analysis how they are affecting the growth in the CRM.
Reasons to Purchase
Learn what the key drivers are for the take up of CRM in the pharmaceutical industry are.
Understand the constraints that are holding back investment in CRM solutions.
Understand how the differences between each nations characteristics are going to affect the growth in each country.